API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215072
https://www.reuters.com/business/healthcare-pharmaceuticals/diabetes-patients-glp-1s-instead-insulin-have-lower-cancer-risk-study-shows-2024-07-05/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218673
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sugarmds-llc-issues-voluntary-nationwide-recall-advanced-glucose-support-supplements-capsules-due
https://www.indianpharmapost.com/news/glenmark-to-launch-a-triple-drug-fdc-of-teneligliptin-dapagliflozin-metformin-in-india-for-type-2-diabetes-14798
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217631
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-acquires-two-diabetes-brands-from-boehringer-ingelheim/articleshow/102841038.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207678
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/akums-gets-dcgi-nod-for-triple-combination-diabetes-medication/articleshow/102172327.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.prnewswire.com/news-releases/fda-approves-new-class-of-medicines-to-treat-pediatric-type-2-diabetes-301855985.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215629
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/diabetes-drug-may-be-the-pill-for-long-covid/articleshow/100858324.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.prnewswire.com/news-releases/treating-covid-with-metformin-reduces-long-covid-rates-301846870.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211921
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211563
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208449
https://endpts.com/merck-viatris-agree-to-settle-patent-feud-surrounding-diabetes-drugs/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-15-2023-86840.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-fixes-retail-price-of-74-drug-formulations/articleshow/98279741.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://health.economictimes.indiatimes.com/news/pharma/usfda-approves-zydus-canagliflozin-and-metformin-hydrochloride-tablets/98089916
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210542
https://www.reuters.com/business/healthcare-pharmaceuticals/merck-set-remove-cancer-causing-chemical-top-diabetes-drugs-bloomberg-news-2023-01-17/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212448
https://www.indianpharmapost.com/news/torrent-enters-into-co-marketing-partnership-with-boehringer-ingelheim-india-13452
https://tiefenbachergroup.com/2022/09/08/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-diabetis-medicine-vildagliptin-and-vildagliptin-metformin-in-africa/
https://www.merck.com/news/u-s-district-court-rules-in-favor-of-merck-in-sitagliptin-phosphate-patent-lawsuit/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pricing-authority-caps-rates-of-key-diabetes-drugs/articleshow/93785721.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212677
https://health.economictimes.indiatimes.com/news/pharma/zydus-receives-final-fda-approval-for-type-2-diabetes-drug/92797033
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212198
https://www.ema.europa.eu/en/documents/overview/vildagliptin/metformin-hydrochloride-accord-epar-medicine-overview_en.pdf
https://www.europeanpharmaceuticalreview.com/news/172292/advancing-nitrosamines-analysis-with-gas-chromatography/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212681
https://www.europeanpharmaceuticalreview.com/news/171874/majority-of-metformin-drugs-have-acceptable-nitrosamine-levels-finds-study/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-13-2022-1649826529.pdf
https://www.ema.europa.eu/en/medicines/human/EPAR/sitagliptin-metformin-hydrochloride-mylan
http://www.pharmafile.com/news/609109/first-oral-diabetes-treatment-approved-europe-use-during-pregnancy
https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-announces-successful-phase-3-topline-results-for-new-antidiabetic-drugs-triple-combination-therapy-301490372.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214629
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-19-2022-1642582122.pdf
https://endpts.com/recall-report-another-month-another-issue-with-ndma/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207577